Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.
Interleukin 6 (IL-6) is an important regulator of the acute phase response, T cell function, and terminal B cell differentiation. Excessive or inappropriate production of this cytokine may be involved in a variety of autoimmune and neoplastic disorders. To investigate the consequences of dysregulate...
Guardat en:
| Publicat a: | J Clin Invest |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
1990
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296765/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2384605/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114749 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|